Business Context and Reporting Period
Company: The Clorox Company
Filing Type: Form 8-K (Current Report)
Date of Report: November 30, 2007
Event: Completion of the acquisition of Burt's Bees, Inc. (BBI).
Key Financial Metrics
This filing reports on a specific transaction rather than periodic financial performance. Key transaction metrics include:
- Total Consideration: Approximately $925 million (net of an additional $25 million payment for anticipated tax benefits).
- Cash Paid at Closing: Approximately $913 million (net of the $25 million tax benefit payment).
- Escrow Amount: $25 million held for up to 6 months to secure potential purchase price adjustments or indemnity claims.
- Ownership: 100% of outstanding BBI equity acquired.
Note: The filing text does not provide clear values for Clorox's revenue, profit, cash flow, margins, debt, or liquidity for the reporting period.
Material Changes
The primary material change is the expansion of Clorox's product portfolio through the acquisition of Burt's Bees, Inc. The transaction was executed via a merger of Buzz Acquisition Corp. (a wholly-owned subsidiary) with and into BBI. Outstanding BBI options were paid out net of applicable exercise prices.
Outlook, Risks, and Contingencies
- Purchase Price Adjustment: The final purchase price is subject to adjustment based on a post-closing review of BBI's working capital as of closing.
- Contingencies: $25 million is held in escrow to cover potential indemnity claims or purchase price adjustments.
- Management Actions: Employment agreements were entered into with certain key BBI employees and assigned to BBI at closing.
Investor Verification Checklist
- Verify the final purchase price after the post-closing working capital review.
- Monitor the release or utilization of the $25 million escrow fund over the next 6 months.
- Review the impact of the acquisition on Clorox's consolidated balance sheet and debt levels in subsequent quarterly filings.
- Assess the retention of key BBI employees under the new employment agreements.